Two Sigma Advisers’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21M | Buy |
1,814,600
+69,800
| +4% | +$808K | 0.04% | 328 |
|
|
2025
Q1 | $15.2M | Buy |
1,744,800
+508,600
| +41% | +$4.44M | 0.03% | 404 |
|
|
2024
Q4 | $17.8M | Buy |
1,236,200
+873,200
| +241% | +$12.5M | 0.04% | 348 |
|
|
2024
Q3 | $8.2M | Buy |
363,000
+141,700
| +64% | +$3.2M | 0.02% | 543 |
|
|
2024
Q2 | $4.3M | Buy |
221,300
+198,800
| +884% | +$3.87M | 0.01% | 828 |
|
|
2024
Q1 | $844K | Buy |
+22,500
| New | +$844K | ﹤0.01% | 1655 |
|
|
2023
Q3 | – | Sell |
-21,500
| Closed | -$1.2M | – | 2579 |
|
|
2023
Q2 | $1.2M | Buy |
+21,500
| New | +$1.2M | ﹤0.01% | 1462 |
|
|
2023
Q1 | – | Sell |
-7,100
| Closed | -$259K | – | 2754 |
|
|
2022
Q4 | $259K | Sell |
7,100
-38,300
| -84% | -$1.4M | ﹤0.01% | 2115 |
|
|
2022
Q3 | $1.29M | Buy |
+45,400
| New | +$1.29M | ﹤0.01% | 1395 |
|
|
2021
Q2 | – | Sell |
-93,700
| Closed | -$17M | – | 2703 |
|
|
2021
Q1 | $17M | Buy |
93,700
+86,300
| +1,166% | +$15.6M | 0.05% | 401 |
|
|
2020
Q4 | $1.05M | Buy |
+7,400
| New | +$1.05M | ﹤0.01% | 1547 |
|